MENU
EDGE
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

EDGE stock forecast, quote, news & analysis

The investment seeks capital appreciation... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
EDGE
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for EDGE with price predictions
Oct 22, 2026

Aroon Indicator for EDGE shows an upward move is likely

EDGE's Aroon Indicator triggered a bullish signal on October 22, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 156 similar instances where the Aroon Indicator showed a similar pattern. In 139 of the 156 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 13 of 16 cases where EDGE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

EDGE moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where EDGE advanced for three days, in 60 of 75 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The 10-day RSI Indicator for EDGE moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In 7 of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at 47%.

The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EDGE as a result. In 15 of 24 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for EDGE turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In 6 of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at 38%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDGE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

EDGE broke above its upper Bollinger Band on October 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Industry description

The investment seeks capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities and derivative instruments that provide exposure to equity securities. To gain this exposure, the fund will primarily invest in one or more ETFs or options on an ETF or index (each, a “reference asset”). The fund is non-diversified.
View a ticker or compare two or three
EDGE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of linical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Category Trading

Category
Derivative Income
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com